Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review

BACKGROUND: The prognosis of gastric cancer (GC) is poor with a median overall survival (OS) of less than 12 months in advanced-stage disease. The search for distinct genetic subgroups of GC patients and predictive biomarkers is ongoing. While BRCA1 or BRCA2 germline mutations (gBRCAm) have potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Halpern, Naama, Grinshpun, Albert, Boursi, Ben, Golan, Talia, Margalit, Ofer, Aderka, Dan, Friedman, Eitan, Laitman, Yael, Hubert, Ayala, Kadouri, Luna, Hamburger, Tamar, Barnes-Kedar, Inbal, Levi, Zohar, Ben-Aharon, Irit, Brenner, Baruch, Goldberg, Yael, Peretz, Tamar, Shacham-Shmueli, Einat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677647/
https://www.ncbi.nlm.nih.gov/pubmed/33235458
http://dx.doi.org/10.2147/OTT.S276814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677647/
https://www.ncbi.nlm.nih.gov/pubmed/33235458
http://dx.doi.org/10.2147/OTT.S276814

Ejemplares similares